Holen Sie sich die Stockscreener-App
4.045
3.74%
0.165
Schlusskurs vom Vortag:
$3.88
Offen:
$3.89
24-Stunden-Volumen:
590.22K
Relative Volume:
0.43
Marktkapitalisierung:
$248.12M
Einnahmen:
$69.23M
Nettoeinkommen (Verlust:
$-33.10M
KGV:
-3.428
EPS:
-1.18
Netto-Cashflow:
$-39.26M
1W Leistung:
+6.76%
1M Leistung:
-17.18%
6M Leistung:
+302.50%
1J Leistung:
+7.62%
1-Tages-Spanne:
$3.89
$4.10
1-Wochen-Bereich:
$3.5827
$4.10
52-Wochen-Spanne:
$0.52
$5.92
Neuronetics Inc Stock (STIM) Company Profile
Firmenname
Neuronetics Inc
Sektor
Branche
Telefon
877-600-7555
Adresse
3222 PHOENIXVILLE PIKE, MALVERN, PA
Vergleichen Sie STIM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
4.045 | 248.12M | 69.23M | -33.10M | -39.26M | -1.18 |
|
TMO
Thermo Fisher Scientific Inc
|
431.50 | 166.47B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
192.91 | 135.88B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
419.93 | 32.74B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
102.61 | 29.40B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
142.87 | 26.30B | 15.41B | 1.37B | 2.11B | 7.50 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2018-07-24 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Neuronetics Inc Aktie (STIM) Neueste Nachrichten
Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call | STIM Stock News - GuruFocus
Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call - The Manila Times
Medical Tech Leader Neuronetics Sets Q1 2025 Earnings Release: Key Details for Neurohealth Investors - Stock Titan
Neuronetics Reports 2024 Financial Results and Strategic Advances - MSN
Transcranial Magnetic Stimulator Market to Witness Remarkable - openPR.com
Neuronetics Announces Expanded Coverage for NeuroStar TMS to Treat Adolescent Depression - MSN
Even though Neuronetics (NASDAQ:STIM) has lost US$30m market cap in last 7 days, shareholders are still up 130% over 5 years - simplywall.st
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression - The Manila Times
Major Insurance Breakthrough: NeuroStar's Teen Depression Treatment Now Covered for 15 Million Lives - Stock Titan
Neuronetics Revises Financial Results for Q4 and Full Year 2024 - MSN
Neuronetics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs (NASDAQ:STIM) - Seeking Alpha
Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results - The Manila Times
Neuronetics Some Non-Cash Revisions Made To Financial Statements Related To Co's Acquisition Of Greenbrook Tms & Shares Outstanding In Q4 - Marketscreener.com
Neuronetics Updates Financial Results: Q4 Losses Deepen After Greenbrook Deal Review - Stock Titan
Transcranial Magnetic Stimulator Market Is Booming So Rapidly - openPR.com
This Penny Stock Is Up 170% in 2025 and Analysts Think It Can Rally Further From Here - The Globe and Mail
FDA Clears NeuroStar's TMS Therapy for Adolescents with Major Depressive Disorder - MSN
While private equity firms own 38% of Neuronetics, Inc. (NASDAQ:STIM), retail investors are its largest shareholders with 43% ownership - Yahoo
Wall Street Analysts Think Neuronetics (STIM) Could Surge 34.98%: Read This Before Placing a Bet - Yahoo Finance
Neuronetics Inc (STIM) Q4 2024 Earnings Report Preview: What To Look For - GuruFocus.com
Transcranial Magnetic Stimulator Market Positioned - openPR
Neuronetics’ SWOT analysis: merger synergies boost growth prospects for stock - Investing.com India
Earnings call transcript: Neuronetics Q4 2024 sees revenue growth, stock rises - Investing.com Australia
Neuronetics, Inc. to Host Earnings Call - ACCESS Newswire
William Blair Increases Earnings Estimates for Neuronetics - Defense World
Neuronetics Inc (STIM) Reports 8% Revenue Growth in Q3 2023 - GuruFocus.com
Neuronetics CFO Stephen Furlong sells $8,364 in stock - Investing.com India
Neuronetics (NASDAQ:STIM) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - Defense World
(STIM) Technical Data - news.stocktradersdaily.com
Neuronetics executive sells shares worth $1,688 By Investing.com - Investing.com Canada
Neuronetics executive sells shares worth $1,688 - Investing.com India
Neuronetics CFO Stephen Furlong sells $8,364 in stock By Investing.com - Investing.com UK
Neuronetics, Inc.'s (NASDAQ:STIM) Shares Leap 69% Yet They're Still Not Telling The Full Story - Simply Wall St
Transcranial Magnetic Stimulator Market Growth and Future - openPR
Neuronetics’ Earnings Call: Growth Amid Challenges - TipRanks
Neuronetics Grants Inducement Awards to New Employees - MSN
Neuronetics, Inc. (NASDAQ:STIM) Q4 2024 Earnings Call Transcript - MSN
Neuronetics stock holds Market Outperform amid merger growth By Investing.com - Investing.com Canada
Neuronetics Inc (STIM) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst Rising Expenses ... By GuruFocus - Investing.com Canada
Neuronetics Inc (STIM) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst Rising Expenses ... - Yahoo Finance
Neuronetics’ Strategic Merger with Greenbrook TMS Fuels Growth and Positive Outlook - TipRanks
Neuronetics Reports Growth Amid Strategic Acquisitions - TipRanks
Canaccord raises Neuronetics stock target to $8, maintains buy rating By Investing.com - Investing.com Australia
Canaccord raises Neuronetics stock target to $8, maintains buy rating - Investing.com India
Finanzdaten der Neuronetics Inc-Aktie (STIM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Neuronetics Inc-Aktie (STIM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| MACAN WILLIAM ANDREW | EVP, GC, CCO and CS |
Mar 04 '25 |
Sale |
4.48 |
377 |
1,689 |
526,805 |
4.80%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):